Hedge Fund Database

RP MANAGEMENT, LLC

Adviser information for RP MANAGEMENT, LLC last updated from Form ADV on March 28th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.

Advisory Business

Type of Organization Limited Liability Company
Fiscal Year End DECEMBER
Legal Location Delaware, United States

Employees

Total Number of Employees 86
Investment Advisory/Research 43
Registered Broker-Dealer Representatives 0
Registered State Investment Advisers 0
Licensed Agents of an Insurance Company 0
No. of Firms/People that Solicit Clients 0

RAUM

Provides Management of Securities Portfolios Yes
Type Accounts RAUM
Discretionary 19 $17.6B
Non-Discretionary 0 $0
Total 19 $17.6B

Clients

Type Number RAUM
Individuals 0 $0
HNW Individuals 0 $0
Banking or thrift institutions 0 $0
Investment companies 0 $0
Business development companies 0 $0
Pooled investment vehicles 19 $17.6B
Pension and profit sharing plans 0 $0
Charitable organizations 0 $0
State or municipal gov entities 0 $0
Other investment advisers 0 $0
Insurance companies 0 $0
Sovereign wealth funds and foreign official institutions 0 $0
Corporations or other businesses 0 $0
Other 0 $0
Type Number
No. of Non-RAUM Clients 0
No. of Non-U.S. Clients 68

Services

Advisory Services Portfolio management for pooled investment vehicles
Compensation % of AUMPerformance-based fees

Identifiers

SEC RIA File Number 801-74235
SEC ERA File Number 801-74235
SEC CIK Numbers 1507673
SEC CRD Numbers 161569
Legal Entity Identifier None

Principal Office

110 EAST 59TH STREET, SUITE 3300
NEW YORK
NY
United States
Monday - Friday, 9AM-6PM
Tel: 212-883-0200, Fax: 212-883-2260

Websites

www.linkedin.com/company/royalty-pharma www.royaltypharma.com

Chief Compliance Officer

CAROLYN RUBIN
110 EAST 59TH STREET, SUITE 3300
NEW YORK
NY
United States
Tel: 212-883-0200
Fax: 212-883-2260
(Full email address available in API data)

Regulatory Contact

ARTHUR MCGIVERN
EXECUTIVE VICE PRESIDENT AND GENERAL COUNSEL
110 EAST 59TH STREET, SUITE 3300
NEW YORK
NY
United States
Tel: 212-883-0200
Fax: 212-883-2260
(Full email address available in API data)

Industry Affiliates

PHARMA MANAGEMENT (CAYMAN) LTD. Sponsor, GP, manager of pooled investment vehicles
PHARMACEUTICAL INVESTORS LP Sponsor, GP, manager of pooled investment vehicles
PHARMAKON ADVISORS, LP Other investment adviser, including financial planners
RPI EPA HOLDINGS, LP Sponsor, GP, manager of pooled investment vehicles

Private Funds

Name Type Assets $USD Min Investment $USD No. Owners
ROYALTY PHARMA SELECT Private Equity Fund $0.0M $0.0M 0
RPI INTERMEDIATE FINANCE PARTNERSHIP, LP Hedge Fund $1,469.4M $0.0M 40
RPI INTERNATIONAL PARTNERS 2019, LP Private Equity Fund $20.2M $0.0M 2
RPI US PARTNERS 2019, LP Private Equity Fund $1,596.8M $0.0M 66

Control Persons

Name Type Entity Title Since Ownership
LEGORRETA, PABLO, GERARDO Individual – CHIEF EXECUTIVE OFFICER AND MANAGING MEMBER 08/2003 50-75%
LLOYD, GEORGE, WINGATE Individual – EXECUTIVE VICE PRESIDENT AND CHIEF LEGAL OFFICER 07/2011 < 5%
ERB, DOUGLAS, PETER Individual – CHIEF ADMINISTRATIVE OFFICER 12/2014 < 5%
COYNE, TERRANCE, PATRICK Individual – CHIEF FINANCIAL OFFICER 03/2019 < 5%
RUBIN, CAROLYN, JUDITH Individual – CHIEF COMPLIANCE OFFICER 03/2022 < 5%
MCGIVERN, ARTHUR, RICHARD Individual – EXECUTIVE VICE PRESIDENT AND GENERAL COUNSEL 10/2022 < 5%
SCHNEIDER, ERIC, CORNELIUS Individual – CHIEF TECHNOLOGY OFFICER 09/2023 < 5%
RP MIP HOLDINGS LLC Domestic Entity – MEMBER 01/2024 25-50%
URIST, MARSHALL, JONATHAN Individual – EXECUTIVE VICE PRESIDENT, HEAD OF RESEARCH AND INVESTMENTS 04/2022 < 5%

No. Employees, Historic

90450201920202021202220232024202519 on 9/16/201929 on 3/27/202046 on 3/30/202146 on 4/29/202146 on 2/3/202267 on 3/30/202275 on 3/31/202375 on 4/28/202375 on 1/31/202486 on 3/28/2024

RAUM, Historic

40B20B0201920202021202220232024202516499880451 on 9/16/201918561164597 on 3/27/202030441923761 on 3/30/202116343772536 on 4/29/202116343772536 on 2/3/202217710040913 on 3/30/202216225658707 on 3/31/202317018838887 on 4/28/202317018838887 on 1/31/202417646826055 on 3/28/2024

No. Clients, Historic

20100201920202021202220232024202513 on 9/16/201916 on 3/27/202017 on 3/30/202119 on 4/29/202119 on 2/3/202219 on 3/30/202219 on 3/31/202319 on 4/28/202319 on 1/31/202419 on 3/28/2024

Holdings

From latest 13F, filed August 13th, 2024 for period ending June 30th, 2024
Name Class Value $USD # Shares Private Fund
BIOHAVEN LTD COM 102M 3M Legorreta Pablo G.
VIRACTA THERAPEUTICS INC COM 2K 4K Legorreta Pablo G.
BIOCRYST PHARMACEUTICALS INC COM 24M 4M Legorreta Pablo G.
CYTOKINETICS, INC COM 53M 980K Legorreta Pablo G.